GlassScriptPhysician profile
Jamie P Olenec
NPI 1093988552
$1,122.46
in general payments reported to CMS, 2019-2025
14 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $14.90 · 2021: $11.23 · 2022: $48.52 · 2023: $41.68 · 2024: $340 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $488.26 | 2019-2025 | |
| Glaxosmithkline, LLC. | $233.08 | 2019-2025 | Nucala |
| Optinose US, INC. | $85.64 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $68.02 | 2019 | |
| Abbvie INC. | $54.01 | 2023-2024 | |
| Stryker Corporation | $52.89 | 2019 | |
| Amgen INC. | $26.85 | 2024 | Tezspire |
| Biocryst US Sales Co., LLC | $22.32 | 2024 | Orladeyo |
| Lilly USA, LLC | $20.42 | 2025 | Zepbound |
| Shire North American Group INC | $19.81 | 2019 | |
| Alk-Abello, INC | $15.73 | 2019 | |
| Hologic Sales and Service, LLC | $12.93 | 2023 | Coolseal Generator |
| Astrazeneca Pharmaceuticals LP | $11.27 | 2019 | |
| Sientra, INC. | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Olenec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.